MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Prothena Co. PLC Company Profile (NASDAQ:PRTA)

Consensus Ratings for Prothena Co. PLC (NASDAQ:PRTA) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $74.60 (110.26% upside)

Analysts' Ratings History for Prothena Co. PLC (NASDAQ:PRTA)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016RBC CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2016Credit SuisseReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2016BarclaysInitiated CoverageOverweight$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016OppenheimerReiterated RatingOutperform$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016WedbushLower Price TargetOutperform$81.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Ladenburg ThalmannBoost Price TargetBuy$49.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/5/2014Bank of AmericaDowngradeNeutral -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Citigroup Inc.Lower Price TargetBuy$60.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Prothena Co. PLC (NASDAQ:PRTA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/3/2016Q116($0.77)($0.81)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2016Q215($0.81)($0.76)$0.39 million$0.31 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015($0.66)($0.73)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q2($0.56)($0.59)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015($0.59)($0.55)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2015Q414($0.66)($0.48)$1.20 million$2.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2014Q314($0.60)($0.48)$1.13 million$1.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2014Q214$0.06$15.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014$0.81$0.78ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014Q113($0.52)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/28/2013Q412($0.82)$0.13 million$0.58 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Prothena Co. PLC (NASDAQ:PRTA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.82)($0.82)($0.82)
Q2 20162($0.90)($0.90)($0.90)
Q3 20162($1.01)($0.99)($1.00)
Q4 20162($1.14)($1.13)($1.14)
(Data provided by Zacks Investment Research)
Dividend History for Prothena Co. PLC (NASDAQ:PRTA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Prothena Co. PLC (NASDAQ:PRTA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/24/2016Dennis J SelkoeDirectorSell5,000$45.00$225,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2016Karin L WalkerInsiderSell4,000$45.11$180,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Dennis J SelkoeDirectorSell5,000$45.00$225,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2016Karin L. WalkerinsiderSell4,000$50.96$203,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Tara NickersoninsiderSell10,000$66.17$661,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Tran NguyenCFOSell30,000$66.17$1,985,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Dennis J. SelkoeDirectorSell3,125$68.74$214,812.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Christopher S. HenneyDirectorSell5,000$75.00$375,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2015Lars EkmanDirectorSell30,000$73.35$2,200,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2015Martin KollerinsiderSell30,000$65.03$1,950,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Arthur W. HomaninsiderSell3,125$52.14$162,937.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Christopher S. HenneyDirectorSell5,000$55.00$275,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015Tara NickersoninsiderSell10,000$56.06$560,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2015Martin KollerinsiderSell30,000$55.56$1,666,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Dennis J. SelkoeDirectorSell3,125$55.45$173,281.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2015Dale B. SchenkCEOSell30,000$56.65$1,699,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2015Karin L WalkerInsiderSell7,000$62.06$434,420.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Tara NickersonInsiderSell12,000$44.41$532,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2015Tara NickersonInsiderSell13,000$39.99$519,870.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Dennis J SelkoeDirectorSell3,125$25.56$79,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Karin L WalkerInsiderSell2,500$20.74$51,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Arthur W HomanInsiderBuy2,000$19.12$38,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014Karin L WalkerInsiderSell8,000$21.58$172,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Dale SchenkCEOBuy8,000$20.79$166,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Tara NickersonInsiderBuy1,656$21.00$34,776.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Gene KinneyInsiderBuy2,500$19.54$48,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Tran NguyenCFOBuy2,200$19.61$43,142.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Co Plc Perrigomajor shareholderSell3,182,253$24.96$79,429,034.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Prothena Co. PLC (NASDAQ:PRTA)
DateHeadline
06/25/16 09:40 AMProthena Corporation plc (PRTA) Jumps 6.24% on June 23 - Equities.com
06/22/16 05:53 PMProthena Corporation plc (NASDAQ:PRTA) Stock Momentum Hits Weakness - CML News
06/22/16 05:53 PMNew Broker Ratings For Prothena Corporation Plc (NASDAQ:PRTA) - FTSE News
06/21/16 03:19 PMProthena to Present at 15th International Symposium on Amyloidosis Showcasing Broad Commitment to Advancing New Therapies for Systemic Amyloidoses - [at noodls] - New clinical data to be presented from Phase 1/2 dose-escalation and expansion trial of NEOD001 for the potential treatment of AL amyloidosis Presentations to highlight data from clinical, preclinical ...
06/20/16 07:31 AMThis Weeks Broker Views For Prothena Corporation Plc (NASDAQ:PRTA) - Fiscal Standard
06/18/16 10:05 AMWeak On High Volume: Prothena (PRTA) - TheStreet.com
06/17/16 07:21 AMProthena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : June 17, 2016 -
06/16/16 10:08 AMHot News: Prothena Corporation plc (NASDAQ:PRTA), Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), KMG ... - KC Register
06/10/16 06:12 PMProthena (PRTA) Flagged As Strong On High Volume - TheStreet.com
06/10/16 08:57 AMProthena Corporation PLC: Credit Suisse Says PRX003 Potential Sales Add to Valuation - Bidness ETC
06/09/16 06:22 PMProthena Corp. (PRTA) Says PRX003 Phase 1 as Novel Anti-MCAM Antibody Met Primary Objective - StreetInsider.com
06/09/16 03:09 PMProthena Reports Results of Phase 1 Single Ascending Dose Study of PRX003, Demonstrating Target Engagement of the Novel Anti-MCAM Antibody for Inflammatory Diseases - [at noodls] - All doses of PRX003 found to be safe and well tolerated, meeting the primary objective of the Phase 1 single ascending dose study in healthy volunteers Neutralization of Th17 cells of greater than 95 percent ...
06/08/16 06:22 PMPROTHENA CORPORATION PLC (NASDAQ:PRTA) Financial Condition Compared to S&P 500 - CML News
06/06/16 09:41 AMNext Weeks Broker Price Targets For Prothena Corporation Plc (NASDAQ:PRTA) - Share Trading News
06/04/16 05:59 PMLatest Analysts Tips Update: Prothena Corporation plc (NASDAQ:PRTA) , The Spectranetics Corporation (NASDAQ ... - Street Updates
06/04/16 05:59 PMProthena Co. PLC (PRTA) Given “Buy” Rating at Credit Suisse - Let Me Know About This
06/02/16 06:21 PMProthena Corporation plc (PRTA) Jumps 5.07% on June 02 - Equities.com - Prothena Corporation plc (PRTA) Jumps 5.07% on June 02Equities.comProthena Corporation plc (PRTA) was among the biggest gainers on the Russell 2000 for Thursday June 02 as the stock popped 5.07% to $50.32, representing a gain of $2.43 per share. Some 680,327 shares traded hands on 5,271 trades, compared with an ...and more »
06/01/16 08:50 AMProthena Corporation Plc (NASDAQ:PRTA) Updated Price Targets - FTSE News - Prothena Corporation Plc (NASDAQ:PRTA) Updated Price TargetsFTSE News02/19/2016 – Prothena Corporation plc had its “outperform” rating reiterated by analysts at Wedbush. They now have a USD 77 price target on the stock. 01/21/2016 – Credit Suisse began new coverage on Prothena Corporation plc giving the company a ...and more »
05/25/16 03:18 PMPROTHENA CORP PLC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or By -
05/23/16 03:16 PMProthena to Present Wide Range of Studies on Amyloidosis, Including New Clinical Data on NEOD001, at International Symposium on Amyloidosis - [at noodls] - New clinical data to be presented from expansion cohort of Phase 1/2 trial of NEOD001 for the potential treatment of AL amyloidosis Additional presentations to highlight data from preclinical and quality ...
05/23/16 03:07 PM4:07 pm Prothena to present new data on NEOD001 at the International Symposium on Amyloidosis -
05/22/16 11:38 PMProthena Corporation Plc (NASDAQ:PRTA) Broker Price Targets For The Coming Week - Share Trading News - Prothena Corporation Plc (NASDAQ:PRTA) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Prothena Corporation plc (NASDAQ:PRTA). The latest reports which are currently in issue on Sunday 22nd of May state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
05/19/16 07:04 PMProthena Corporation plc: Prothena to Present Quality of Life Data on AL Amyloidosis at European Hematology Association 21st Congress - DUBLIN, Ireland, 2016-05-19 22:05 CEST (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today announced ...
05/19/16 03:52 PMProthena to Present Quality of Life Data on AL Amyloidosis at European Hematology Association 21st Congress - [at noodls] - DUBLIN, Ireland, May 19, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ...
05/17/16 06:49 PMProthena Corporation plc (PRTA) Jumps 5.68% on May 16 - Equities.com - Prothena Corporation plc (PRTA) Jumps 5.68% on May 16Equities.comProthena Corporation plc (PRTA) was among the biggest gainers on the Russell 2000 for Monday May 16 as the stock popped 5.68% to $42.99, representing a gain of $2.31 per share. Some 606,146 shares traded hands on 5,569 trades, compared with an ...Were Analysts Bullish Prothena Corporation PLC (NASDAQ:PRTA) This Week?Franklin IndependentProthena Corporation Plc (NASDAQ:PRTA) Broker Price Targets For The Coming WeekShare Trading NewsInvestors Checklist Stocks: Amarin Corporation PLC (NASDAQ:AMRN) , Prothena Corporation plc (NASDAQ:PRTA)Street UpdatesBenchmark Monitorall 9 news articles »
05/17/16 07:26 AMProthena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : May 17, 2016 -
05/13/16 07:33 PMProthena Corporation Plc Ord WI (NASDAQ:PRTA) Shorts Decreased by 3.59% After Short Covering - B.O.D.Y Confidential - Prothena Corporation Plc Ord WI (NASDAQ:PRTA) Shorts Decreased by 3.59% After Short CoveringB.O.D.Y ConfidentialThe stock of Prothena Corporation Plc Ord WI (NASDAQ:PRTA) registered a decrease of 3.59% in short interest. PRTA's total short interest was 4.20 million shares in May as published by FINRA. Its down 3.59% from 4.35 million shares, reported previously.Are Analysts Bullish Prothena Corporation PLC (NASDAQ:PRTA) After Last Week?The Postall 2 news articles »
05/13/16 07:33 PMProthena Corporation plc (PRTA) Jumps 5.85% on May 13 - Equities.com - Risers & FallersProthena Corporation plc (PRTA) Jumps 5.85% on May 13Equities.comProthena Corporation plc (PRTA) was among the biggest gainers on the Russell 2000 for Friday May 13 as the stock popped 5.85% to $40.68, representing a gain of $2.25 per share. Some 502,030 shares traded hands on 5,454 trades, compared with an ...Prothena Corporation PLC (PRTA) is Initiated by Barclays to Overweight, Price Target at $60Market DigestTake a look at Price Fluctuations: Prothena Corporation plc (NASDAQ:PRTA) , Amedica Corporation (NASDAQ:AMDA)Street UpdatesProthena Corporation plc (NASDAQ:PRTA) Basic Consolidated EPS At $-2.6582Enterprise LeaderThe Post -StreetInsider.com -Finance Dailyall 11 news articles »
05/13/16 11:34 AMCoverage initiated on Prothena by Barclays -
05/12/16 03:51 PMETF’s with exposure to Prothena Corp. Plc : May 12, 2016 -
05/11/16 01:06 AMBlackrock Fund Advisors Bought A Little More Prothena Corporation plc (PRTA) Stock - Here are a few additional firms who have increased or decreased their stake in (PRTA). As of quarter end Blackrock ... The value of the company’s investment in Prothena Corporation plc decreased from $52,534,000 to $34,850,000 a change of $17,684,000 ...
05/09/16 07:16 PMPROTHENA CORPORATION PLC - DUBLIN, Ireland, 2016-05-09 22:05 CEST (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today announced ...
05/09/16 03:08 PMProthena to Present Clinical Results From its Phase 1 Single Ascending Dose Study of PRX003, an Anti-MCAM Antibody Being Investigated for Inflammatory Diseases, at EULAR 2016 - [at noodls] - DUBLIN, Ireland, May 09, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel ...
05/06/16 09:50 AMProthena Corp. Plc :PRTA-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/06/16 01:46 AMProthena Corporation plc (PRTA) Drops 7.15% on May 04 - Equities.com - Web Breaking NewsProthena Corporation plc (PRTA) Drops 7.15% on May 04Equities.comProthena Corporation plc (PRTA) was one of the Russell 2000's biggest losers for Wednesday May 04 as the stock slid 7.15% to $38.59, a loss of $-2.97 per share. Starting at an opening price of $40.71 a share, the stock traded between $38.34 and $41.42 ...Prothena Co. PLC (NASDAQ:PRTA) Given Consensus Rating of "Buy" by AnalystsWeb Breaking NewsAverage Analyst Rating for Prothena Corporation plc (NASDAQ:PRTA)B.O.D.Y Confidentialall 3 news articles »
05/05/16 07:57 AMProthena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : May 5, 2016 -
05/04/16 07:45 PMProthena (PRTA) Reports Wider-than-Expected Loss in Q1 - Nasdaq - Prothena (PRTA) Reports Wider-than-Expected Loss in Q1NasdaqProthena Corporation plc PRTA reported a loss of 81 cents per share in the first quarter of 2016, much wider than both the Zacks Consensus Estimate of a loss of 70 cents and the year-ago loss of 55 cents. A significant increase in R&D expenses led to ...Prothena Reports First Quarter 2016 Financial Results and Provides R&D UpdateGlobeNewswire (press release)all 2 news articles »
05/04/16 12:00 PMProthena (PRTA) Reports Wider-than-Expected Loss in Q1 -
05/04/16 05:13 AMPROTHENA CORP PLC Files SEC form 10-Q, Quarterly Report -
05/03/16 03:13 PMPROTHENA CORP PLC Files SEC form 8-K, Results of Operations and Financial Condition -
05/03/16 03:10 PMProthena Reports First Quarter 2016 Financial Results and Provides R&D Update - [at noodls] - Net cash used in operating and investing activities was $25.4 million in the first quarter; strong quarter-end cash position of $474.3 million, including net proceeds of $128.6 million raised through January ...
05/02/16 09:14 PMTrader's Recap: Goldcorp Inc. (NYSE:GG), Prothena Corporation plc (NASDAQ:PRTA), International Business ... - KC Register - Trader's Recap: Goldcorp Inc. (NYSE:GG), Prothena Corporation plc (NASDAQ:PRTA), International Business ...KC RegisterOn last trading day company shares ended up at $20.15. Goldcorp Inc. (NYSE:GG) distance from 50-day simple moving average (SMA50) is 23.96%. Prothena Co. PLC (NASDAQ:PRTA) is set to release its earnings data after the market closes on Tuesday, ...Prothena Corporation Plc Ord WI (NASDAQ:PRTA) Shorts Decreased by 3.59% After Short CoveringThe PostProthena Corporation plc (NASDAQ:PRTA): Quick Look at Earnings PredictionsNews Tribuneall 4 news articles »
04/27/16 05:42 PMProthena (PRTA): What's Ahead for the Stock in Q1 Earnings? -
04/13/16 08:26 PMBrokerages gives Consensus Recommendation of “Buy” to Prothena Co. PLC (NASDAQ:PRTA) - Washington News Wire - Mas Market NewsBrokerages gives Consensus Recommendation of “Buy” to Prothena Co. PLC (NASDAQ:PRTA)Washington News WireProthena Co. PLC logo Shares of Prothena Co. PLC (NASDAQ:PRTA) have been given an average rating of “Buy” by the seven research firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a ...Prothena Co. PLC (NASDAQ:PRTA) Given Consensus Recommendation of "Buy" by BrokeragesMas Market NewsMoving Stocks: Basic Energy Services, Inc. (NYSE:BAS), Optical Cable Corp. (NASDAQ:OCC), Prothena Corporation ...Stock Transcriptall 3 news articles »
04/12/16 01:32 AMInvestors Land PRTA 16.2% Cheaper Than Its Secondary Stock Offering - Looking back to 95 days ago, Prothena Corp plc (NASD: PRTA) priced a 2,250,000 share secondary stock offering at $53.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the ...
04/08/16 04:00 AMProthena Corporation plc (PRTA) Jumps 7.82% on April 06 - Equities.com - Prothena Corporation plc (PRTA) Jumps 7.82% on April 06Equities.comProthena Corporation plc (PRTA) was among the biggest gainers on the Russell 2000 for Wednesday April 06 as the stock popped 7.82% to $46.88, representing a gain of $3.4 per share. Some 460,329 shares traded hands on 4,406 trades, compared with ...
04/06/16 09:40 PMProthena Corporation PLC (NASDAQ:PRTA)'s Stock Insider Transaction – Dennis Selkoe Sells 5000 Shares - RiversideGazette.com - Prothena Corporation PLC (NASDAQ:PRTA)'s Stock Insider Transaction – Dennis Selkoe Sells 5000 SharesRiversideGazette.comDennis Selkoe; that is an insider in Prothena Corp Plc who is the newest to sell shares in the company for which he is right now a director. He in the last few days unloaded some 5,000 shares of the company, with a total value $225,000 U.S. Dollars ...
04/04/16 08:58 PMCompany Shares of Prothena Corporation plc (NASDAQ:PRTA) Rally 6.87% - Everything HUDSON - Company Shares of Prothena Corporation plc (NASDAQ:PRTA) Rally 6.87%Everything HUDSONProthena Corporation plc (NASDAQ:PRTA) has climbed 6.87% in the past week and advanced 19.47% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 4.97% and the outperformance has advanced to 15.27% for the last 4 ...Prothena Corporation plc (NASDAQ:PRTA): Where are Shares Headed?Uptick Analystall 3 news articles »
04/02/16 01:16 AMProthena (PRTA) Strong On High Relative Volume Today - See the FREE profile for PRTA NOW at Trade-Ideas More details on PRTA: Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on the discovery, development, and commercialization of novel protein immunotherapies for the treatment of ...
04/01/16 07:59 PMEarnings Outlook on Prothena Corporation plc (NASDAQ:PRTA) - RiversideGazette.com - Earnings Outlook on Prothena Corporation plc (NASDAQ:PRTA)RiversideGazette.comAnalysts and investors will be looking forward to the next earnings release from Prothena Corporation plc (NASDAQ:PRTA) which is scheduled to be on or around 2016-05-03 for the period ending 2016-03-31. Covering sell-side analysts have a current ...and more »
About Prothena Co. PLC

Prothena Co. PLC logoProthena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis (PRX003). The Company has generated monoclonal antibodies that selectively bind to amyloidogenic (diseased) forms of the Transthyretin (TTR)-mediated amyloidosis (ATTR) protein. Its pipeline also includes late discovery-stage programs for which the Company is testing the efficacy of antibodies in preclinical models of diseases related to amyloid or cell adhesion. NEOD001 is a monoclonal antibody that specifically targets the amyloid that accumulates in AL amyloidosis.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PRTA
  • CUSIP:
Key Metrics:
  • Previous Close: $35.48
  • 50 Day Moving Average: $43.64
  • 200 Day Moving Average: $44.98
  • P/E Ratio: N/A
  • P/E Growth: 0.07
  • Market Cap: $1.22B
  • Current Quarter EPS Consensus Estimate: $-3.72 EPS
Additional Links:
Prothena Co. PLC (NASDAQ:PRTA) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha